PFE: Analysis & Opinions

  1. Endo Health Solutions Needs Some Solutions Of Its Own

    November 07, 2012
    Can Endo reestablish itself as a quality healthcare name?
  2. Bayer Buys Schiff Nutrition International: Winners All ...

    November 07, 2012
    Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
  3. Pfizer to Pay $1.25 Million to Isis - Analyst Blog

    November 05, 2012
    Isis Pharmaceuticals Inc. (ISIS) recently announced that Pfizer Inc. (PFE) will move EXC 001 (also known as as ...
  4. Teva Likely To Tread Water Ahead Of New Strategy

    November 05, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  5. Stock Market News for November 2, 2012 - Market News

    November 02, 2012
    Benchmarks finished in the green on the first trading day of November banking on positive consumer confidence and ...
  6. Pfizer Misses on Revs, Narrows View - Analyst Blog

    November 01, 2012
    Pfizer Inc. (PFE) posted third quarter earnings of 53 cents per share, a penny above the Zacks Consensus Estimate ...
  7. Glaxo Misses on Both Counts - Analyst Blog

    November 01, 2012
    GlaxoSmithKline (GSK) reported third quarter 2012 earnings of 71 cents per American Depository Share (ADS), well ...
  8. Economic Data Deluge Today - Analyst Blog

    November 01, 2012
    We have a flood of economic and earnings reports this morning, but the focus will be on the labor market today ahead ...
  9. Ahead of Wall Street - Nov. 1, 2012 - Ahead of Wall Street

    November 01, 2012
    Thursday, November 1, 2012 We have a flood of economic and earnings reports this morning, but the focus will be ...
  10. Pfizer's Third Quarter Earnings Report

    November 01, 2012
    Pfizer (NYSE:PFE) announced its results for the most recent quarter on November 1, 2012. Pfizer is a global ...
  11. Priority FDA Review for Stivarga - Analyst Blog

    October 31, 2012
    Recently, the HealthCare unit of Bayer (BAYRY) announced that its oncology drug Stivarga (regorafenib) will be ...
  12. Solid Quarter at Dr. Reddy's - Analyst Blog

    October 31, 2012
    Dr. Reddy's Laboratories (RDY) reported second quarter fiscal 2013 earnings per American Depositary Share (ADS) of ...
  13. Markets Stay Closed, Some Earnings Delays - Analyst Blog

    October 30, 2012
    Markets remain closed for a second day on Tuesday due to Hurricane Sandy, with published accounts putting the ...
  14. Ahead of Wall Street - October 30, 2012 - Ahead of Wall ...

    October 30, 2012
    Tuesday, October 30, 2012 Markets remain closed for a second day on Tuesday due to Hurricane Sandy, with ...
  15. Loss at Elan Wider than Expected - Analyst Blog

    October 25, 2012
    Elan Corporation's (ELN) loss of 5 cents per share (excluding special items) for the second quarter of 2012 was ...
  16. Pfizer Third Quarter Earnings Preview

    October 25, 2012
    When Pfizer (NYSE:PFE) releases its third quarter earnings on Tuesday, October 30, 2012, analysts are expecting a ...
  17. Generic Plavix Hurts Bristol-Myers - Analyst Blog

    October 24, 2012
    Bristol-Myers Squibb Company's (BMY) second quarter 2012 earnings (excluding special items) of 48 cents per share ...
  18. Beat and Raise Quarter for Amgen - Analyst Blog

    October 24, 2012
    Amgen (AMGN) continued its strong performance in 2012 with third quarter earnings coming in at $1.66 per share, 23 ...
  19. Pfizer Bullish Engulfing Formed

    October 19, 2012
    New York, October 19th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) ended the trading session higher ...
  20. NVO Looking to Expand Portfolio - Analyst Blog

    October 17, 2012
    Denmark-based Novo Nordisk (NVO) is seeking regulatory approval for its hemophilia A candidate turoctocog alfa ...
Marketplace
Trading Center